Clearogen Clinical Study (Sulphur Trials)

In a multi-center 8 week, double-blind, placebo-controlled, randomised clinical trial, Clearogen was compared to Sulphur 3% in effectiveness.

Clearogen significantly outperformed Sulphur 3% by reducing both inflammatory and non-inflammatory problem skin lesions.
Clearogen resulted in a significant reduction in signs of irritation (erythema), indicating effectiveness without skin irritation.
Clearogen decreased sebum production confirming its ability to reduce DHT, the root cause of problem skin.
Read the full study

Clearogen DHT Study

The ability of Clearogen Anti-Blemish  Lotion to reduce DHT production in skin was tested by Bio-Alternatives, on Reconstructed Human Epidermis (Living Human Skin) in a laboratory setting.

Clearogen Anti-Blemish Lotion reduced the transformation of Testosterone to DHT significantly (49%).
Clearogen prevented transformation of Testosterone and DHT into other metabolites.
Read the full study